Hedge Fund and Insider Trading News: Clint Carlson, Bandera Partners, TheStreet, Inc. (TST), Eidos Therapeutics Inc (EIDX), Arcimoto Inc (FUV), and More

Insider Buying: TheStreet, Inc. (TST) Major Shareholder Purchases 627,220 Shares of Stock (WeekHerald.com)
TheStreet, Inc. (NASDAQ:TST) major shareholder Cannell Capital LLC acquired 627,220 shares of TheStreet stock in a transaction dated Tuesday, December 11th. The stock was purchased at an average cost of $2.05 per share, for a total transaction of $1,285,801.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission.

Insider Buying: Eidos Therapeutics Inc (NASDAQ:EIDX) Major Shareholder Buys 2,853,848 Shares of Stock (FairFieldCurrent.com)
Eidos Therapeutics Inc (NASDAQ:EIDX) major shareholder Bridgebio Pharma Llc purchased 2,853,848 shares of the firm’s stock in a transaction on Wednesday, December 5th. The stock was bought at an average cost of $14.92 per share, with a total value of $42,579,412.16. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Insider Buying: Arcimoto Inc (NASDAQ:FUV) CEO Acquires 139,903 Shares of Stock (MareaInformativa.com)
Arcimoto Inc (NASDAQ:FUV) CEO Mark Frohnmayer bought 139,903 shares of the stock in a transaction that occurred on Monday, November 19th. The stock was bought at an average price of $3.00 per share, with a total value of $419,709.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission.

Insider Buying: Platform Specialty Products Corp (PAH) Director Acquires $1,647,697.50 in Stock (PressOracle.com)
Platform Specialty Products Corp (NYSE:PAH) Director Martin E. Franklin bought 150,750 shares of the company’s stock in a transaction dated Monday, December 10th. The stock was purchased at an average cost of $10.93 per share, for a total transaction of $1,647,697.50. The acquisition was disclosed in a document filed with the Securities & Exchange Commission.

Insider Selling: AnaptysBio Inc (ANAB) CEO Sells 65,585 Shares of Stock (WeekHerald.com)
AnaptysBio Inc (NASDAQ:ANAB) CEO Hamza Suria sold 65,585 shares of AnaptysBio stock in a transaction on Wednesday, December 12th. The shares were sold at an average price of $71.47, for a total value of $4,687,359.95. Following the transaction, the chief executive officer now directly owns 65,649 shares of the company’s stock, valued at $4,691,934.03. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.